2,025 reports of this reaction
11.9% of all VISMODEGIB reports
#1 most reported adverse reaction
MUSCLE SPASMS is the #1 most commonly reported adverse reaction for VISMODEGIB, manufactured by Genentech, Inc.. There are 2,025 FDA adverse event reports linking VISMODEGIB to MUSCLE SPASMS. This represents approximately 11.9% of all 17,013 adverse event reports for this drug.
Patients taking VISMODEGIB who experience muscle spasms should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
MUSCLE SPASMS is a frequently reported adverse event for VISMODEGIB, accounting for a significant proportion of all reports.
In addition to muscle spasms, the following adverse reactions have been reported for VISMODEGIB:
The following drugs have also been linked to muscle spasms in FDA adverse event reports:
MUSCLE SPASMS has been reported as an adverse event in 2,025 FDA reports for VISMODEGIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
MUSCLE SPASMS accounts for approximately 11.9% of all adverse event reports for VISMODEGIB, making it one of the most commonly reported side effect.
If you experience muscle spasms while taking VISMODEGIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.